Valerie D. Riddle
Director/Board Member at University of South Florida Foundation, Inc.
Profile
Valerie D.
Riddle is currently the Director at the University of South Florida Foundation, Inc. She previously worked as the Senior Director-Medical Sciences at MedImmune LLC in 1998-1999, Vice President & Medical Director at PharmAthene, Inc. in 2003-2007 and 2007-2010, Director-HIV Service at Washington Hospital Center Corp., and Vice President-Clinical & Medical Affairs at Guilford Pharmaceuticals, Inc. Dr. Riddle received her undergraduate degree in 1984 and doctorate in 1989 from the University of South Florida.
Valerie D. Riddle active positions
Companies | Position | Start |
---|---|---|
University of South Florida Foundation, Inc. | Director/Board Member | 2012-06-17 |
Former positions of Valerie D. Riddle
Companies | Position | End |
---|---|---|
Pharmathene US Corp.
Pharmathene US Corp. BiotechnologyHealth Technology Part of Altimmune, Inc., Pharmathene US Corp. develops medical countermeasures to prevent and treat morbidity and mortality associated with biological and chemical weapons. | Chief Tech/Sci/R&D Officer | 2007-08-02 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Chief Tech/Sci/R&D Officer | 2007-08-01 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 1998-12-31 |
Washington Hospital Center Corp.
Washington Hospital Center Corp. Hospital/Nursing ManagementHealth Services Washington Hospital Center Corp. provides healthcare services. The firm has care centers for cancer, cardiovascular conditions, and ophthalmologic therapies. Its services include organ transplantation and a regional burn treatment center. The company was founded in March 1958 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Chief Tech/Sci/R&D Officer | - |
Training of Valerie D. Riddle
University of South Florida | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 7 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Health Technology |
Washington Hospital Center Corp.
Washington Hospital Center Corp. Hospital/Nursing ManagementHealth Services Washington Hospital Center Corp. provides healthcare services. The firm has care centers for cancer, cardiovascular conditions, and ophthalmologic therapies. Its services include organ transplantation and a regional burn treatment center. The company was founded in March 1958 and is headquartered in Washington, DC. | Health Services |
University of South Florida Foundation, Inc. | Miscellaneous |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
Pharmathene US Corp.
Pharmathene US Corp. BiotechnologyHealth Technology Part of Altimmune, Inc., Pharmathene US Corp. develops medical countermeasures to prevent and treat morbidity and mortality associated with biological and chemical weapons. | Health Technology |
- Stock Market
- Insiders
- Valerie D. Riddle